Clinical Site 122 — Marietta, Georgia

Clinical Site 122 is a clinical research site located in Marietta, Georgia, United States 30060.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Site 122 has participated in 1 clinical trials.

Therapeutic areas: Adjunctive Treatment of Major Depressive Disorder.

Sponsors: Clexio Biosciences Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 122?

Clinical Site 122 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 122 conducted?

Clinical Site 122 has 1 clinical trials on record. Their work covers Adjunctive Treatment of Major Depressive Disorder.

Is Clinical Site 122 accredited by Crixeo Health?

Clinical Site 122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.